David is Investment Director in the Korys life sciences team and manages the direct and fund investment activities. He also acts as an advisor for the OMX Europe Investment Fund – a Korys & Mérieux Equity Partners co-sponsored investment vehicle – dedicated to venture capital investments in healthcare and nutrition in both Europe and North America.
By supporting and guiding young state-of-the-art biotech companies to success, it is David’s ultimate ambition to improve patients’ health and thereby also contribute to one of the core goals of Korys.
Before joining Korys in 2021, David was active in the venture capital and biotech space for more than 15 years. He studied the relationship between international venture capital investors and their portfolio companies in Europe and then joined PMV, first as (Senior) Investment Manager in the fund business unit and later in the Life Sciences direct investments unit. Finally, at UCB he was the Head of the Immunology R&D Insights to Impact team and acted as an independent scientific, strategic, and financial sparring partner, providing (internal & external) insights and transversal resource reallocation challenges for early and late-stage immunology business units.
Family, friends and sports are important to David. He is the proud father of two young sons with whom he loves to spend time to disconnect. Whenever time allows for it, cycling helps him to clear his head and recharge his batteries.
David holds a Master in Pharmaceutical Sciences and a Master in Economics and Business Administration from Ghent University, as well as a PhD in Entrepreneurial Finance from Vlerick Business School.